drugset / Trial / NCT03382717

Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

NCT03382717

Completed 102 enrolled Oystershell NV
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the effect of the medical device "Excilor® Forte" in the treatment of toenail onychomycosis. Half of the participants will receive the tested product and the other half will receive a comparator (Amorolfin 5%). Patients will be followed during 6 months.

Timeline

Start
2016-10-26
Primary completion
2017-08-26
Completion
2017-08-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amorolfine Small molecule 5 % Topical